Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses†
Open Access
- 19 April 2005
- journal article
- viral hepatitis
- Published by Wolters Kluwer Health in Hepatology
- Vol. 41 (5) , 1004-1012
Abstract
The persistent nature of hepatitis C virus (HCV) infection suggests that HCV encodes proteins that enable it to overcome host antiviral responses. Toll‐like receptor 3 (TLR3)‐mediated signaling, which recognizes the double‐stranded RNA that is produced during viral replication and induces type I interferons, including interferon β (IFN‐β), is crucial to the host defense against viruses. Recent studies suggest that a TIR domain–containing adaptor protein, TRIF, and two protein kinases, TANK‐binding kinase‐1 (TBK1) and IκB kinase‐ϵ (IKKϵ), play essential roles in TLR3‐mediated IFN‐β production through the activation of the transcriptional factor interferon regulatory factor 3 (IRF‐3). We report that the HCV NS3 protein interacts directly with TBK1, and that this binding results in the inhibition of the association between TBK1 and IRF‐3, which leads to the inhibition of IRF‐3 activation. In conclusion, these results suggest the mechanisms of the inhibition of the innate immune responses of HCV infection by NS3 protein. Supplementary material for this article can be found on the HEPATOLOGY website (http://www.interscience.wiley.com/jpages/0270‐9139/suppmat/index.html). (HEPATOLOGY 2005;41:1004–1012.)Keywords
This publication has 36 references indexed in Scilit:
- Innate immunity: an overviewMolecular Immunology, 2004
- Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-β (TRIF) Associates with TNF Receptor-Associated Factor 6 and TANK-Binding Kinase 1, and Activates Two Distinct Transcription Factors, NF-κB and IFN-Regulatory Factor-3, in the Toll-Like Receptor SignalingThe Journal of Immunology, 2003
- Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor SignalingThe Journal of Immunology, 2002
- Toll-like receptors: critical proteins linking innate and acquired immunityNature Immunology, 2001
- Structure of Mouse Interferon Stimulated Gene Factor 3 (ISGF3 / p48) cDNA and Chromosomal Localization of the GeneThe Journal of Biochemistry, 1996
- Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in JapanHepatology, 1995
- Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis.Proceedings of the National Academy of Sciences, 1991
- Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end.Proceedings of the National Academy of Sciences, 1991
- Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.Proceedings of the National Academy of Sciences, 1990
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989